Drug Test Kit Spec Sheet.docx

This specification sheet details 21-panel drug test kits procured by a Pennsylvania municipality through a micro or small order purchase opportunity to the lowest responsive and responsible bidder. The kits feature secure, leak-proof click-top lids with built-in temperature strips to validate sample integrity and accommodate large sample volumes for accurate results. Each kit includes 21 drug and analyte panels with specific cut-off thresholds (in ng/mL) ranging from 10 ng/mL for Buprenorphine to 1000 ng/mL for Amphetamine, Methamphetamine, Gabapentin, Ketamine, and Xylazine, plus three adulterant tests to verify sample authenticity. The analytes screened include common controlled substances such as cocaine, opiates, methamphetamine, benzodiazepines, THC, and fentanyl, as well as emerging substances including synthetic cannabinoids, Kratom, Xylazine, and Psilocybin. Results are delivered rapidly through color-strip read-out typically within five minutes of collection.

The procurement will be awarded as a whole or by line item, whichever serves the city's best interests, with all sellers required to quote all items to be considered eligible for award. No delivery or services shall commence until notification from the department. The specification sheet does not contain information regarding pricing terms, quantities ordered, response deadlines, award dates, contract terms, or renewal options, as these details are not included in the provided documentation.